Nuveen Asset Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $21.4K | Hold |
16,797
| – | – | ﹤0.01% | 3322 |
|
|
2024
Q3 | $34.8K | Hold |
16,797
| – | – | ﹤0.01% | 3328 |
|
|
2024
Q2 | $64K | Hold |
16,797
| – | – | ﹤0.01% | 3320 |
|
|
2024
Q1 | $79.6K | Hold |
16,797
| – | – | ﹤0.01% | 3257 |
|
|
2023
Q4 | $71.7K | Buy |
16,797
+2,993
| +22% | +$12.8K | ﹤0.01% | 3297 |
|
|
2023
Q3 | $42.7K | Hold |
13,804
| – | – | ﹤0.01% | 3160 |
|
|
2023
Q2 | $62.1K | Buy |
+13,804
| New | +$62.1K | ﹤0.01% | 3171 |
|
|
2022
Q2 | – | Sell |
-66,421
| Closed | -$490K | – | 3365 |
|
|
2022
Q1 | $490K | Buy |
66,421
+25,904
| +64% | +$191K | ﹤0.01% | 3024 |
|
|
2021
Q4 | $504K | Sell |
40,517
-4,882
| -11% | -$60.7K | ﹤0.01% | 3072 |
|
|
2021
Q3 | $1.42M | Buy |
45,399
+8,240
| +22% | +$258K | ﹤0.01% | 2832 |
|
|
2021
Q2 | $1.06M | Sell |
37,159
-187
| -0.5% | -$5.36K | ﹤0.01% | 2982 |
|
|
2021
Q1 | $1.62M | Buy |
37,346
+2,624
| +8% | +$114K | ﹤0.01% | 2711 |
|
|
2020
Q4 | $2.48M | Buy |
+34,722
| New | +$2.48M | ﹤0.01% | 2404 |
|